































Assessing	 nanoparticle	 toxicity	 in	 cell‐based	 assays:	 Influence	 of	 cell	 culture	
parameters	and	optimized	models	for	bridging	the	in	vitro‐in	vivo	gap.	
	













The	 number	 of	 newly	 engineered	 nanomaterials	 is	 vastly	 increasing	 and	 so	 are	 their	
applications.	Even	though	a	lot	of	interest	and	effort	are	being	put	into	the	development	of	
nano‐based	biomedical	applications,	the	level	of	translational	clinical	output	remains	limited	
due	 to	 uncertainty	 on	 the	 toxicological	 profiles	 of	 the	 nanoparticles	 (NP).	 As	NP	 used	 in	
biomedicines	are	 likely	to	directly	 interact	with	cells	and	biomolecules,	 it	 is	 imperative	to	








































toothpastes	 and	 AgNP	 can	 be	 found	 in	 food	 packages,	 deodorants	 and	 are	 applied	 as	 a	
preservative	in	cosmetics	1‐3.		
Given	 the	ever	 increasing	use	of	NP	 in	 technological	applications	and	everyday	consumer	
goods	and	the	high	 interest	of	exploiting	 the	exceptional	 features	of	 the	NP	 in	biomedical	
applications,	 it	 is	 expected	 that	 both	 intentional	 and	 unintentional	 exposure	will	 become	
more	 frequent	 4,	5.	Because	of	 this,	 the	 increase	 in	nanotechnology	 implementation	 in	our	
daily	lives	is	joined	with	the	raising	of	concerns	on	potential	adverse	effects	towards	human	
health	6.	It	is	therefore	recommended	that	the	safety	of	these	products,	towards	consumers	
and	 especially	 towards	 workers	 at	 the	 production	 site,	 is	 carefully	 evaluated	 before	 its	
introduction	to	the	market	4,	5,	7.	However,	there	are	currently	only	very	limited	regulations	
on	the	use	and	the	safety	criteria	for	nanomaterials	in	industrial	applications	or	consumer	
goods.	Major	obstacles	on	 the	 route	 to	an	appropriate	 legislation	are	 the	broad	nature	of	
nanotechnology,	the	incredible	pace	at	which	the	field	keeps	advancing	and	the	enormous	
variety	 in	 types	 of	 nanomaterials,	 each	 with	 different	 physicochemical	 properties	 and	
specific	applications	7.	An	appropriate	legislation	should	cover	all	aspects	of	nanotechnology	
without	any	material	or	application	being	left	out,	which	from	a	practical	point	of	view,	 is	







range	 from	1	 ‐	100	nm	8.”	As	every	definition	has	 its	 limitations	and	 introduces	 technical	








monitoring	 of	 the	 delivery	 efficiency	 after	 administration	 and	 Kirui	 et	 al.	 created	 an	
immunotargeted	 gold‐coated	 iron	 oxide	 NP	 (IONP)	 to	 visualise	 colorectal	 tumours	 by	
magnetic	resonance	imaging	followed	by	treatment	with	hyperthermia	23,24.						
It	is	due	to	the	minute	dimensions	of	the	NP	that	they	exhibit	many	unique	properties	(e.g.	
IONP	are	superparamagnetic	 25	and	AuNP	have	a	 localised	surface	plasmon	resonance	 26)	




as	 the	nanomaterial‐paradox	and	underscores	 the	 importance	of	 a	 thorough	 toxicological	
analysis	9.	Even	though	nanotechnology	has	been	evolving	since	the	1980’s,	 it	was	only	in	
2004	that	Donaldson	et	al.	mentioned	the	importance	of	nanotoxicology	‐	as	a	subcategory	of	




with	 an	 emphasis	 on	 establishing	 a	 relationship,	 if	 any,	 between	 the	 physicochemical	
properties	of	the	NP	and	the	toxicological	responses	31.	It	is	crucial	to	view	nanotoxicology	as	
a	distinct	 category	of	 toxicology	 since	 it	 has	been	observed	 that	 standard	 toxicity	 assays,	
which	 were	 initially	 developed	 for	 the	 evaluation	 of	 pharmacological	 agents,	 are	 often	
inadequate	for	nanotoxicity	assessment.	This	can	be	attributed	to	the	different	mechanisms	
through	which	NP	may	evoke	toxic	effects,	the	specific	behaviour	of	the	NP	in	culture	media	
and	the	possible	 interference	of	NP	with	various	 in	vitro	and	 in	vivo	 toxicity	assays	9,	32‐34.	
Therefore	 the	classic	 toxicity‐testing	paradigm	needs	 to	be	optimised	 to	be	applicable	 for	






Furthermore	we	will	 propose	 adjustments	 that	 can	 be	made	 to	 the	 cultivation	 system	 to	
optimise	the	current	in	vitro	models	in	order	to	minimize	artefacts	and	more	closely	resemble	












Important	 factors	 in	 this	 respect	 are	 the	 higher	 surface	 to	 volume	 ratio,	 higher	 surface	
reactivity	and	susceptibility	 to	degradation	and	 ionleaching	28,	39.	Furthermore	NP	tend	to	
behave	 differently	 in	 dispersion	 in	 comparison	 to	 chemicals	 as	 some	 are	 prone	 to	
degradation,	 agglomeration	or	aggregation	and	sedimentation,	 influencing	NP	uptake	and	
subsequently	NP	 toxicity	 35,	 40,	 41.	 Since	 these	 effects,	 as	well	 as	 other	 adverse	 effects,	 are	
highly	dependent	on	the	physicochemical	properties	of	the	NP	a	thorough	characterisation	
in	 both	 the	 dry	 state	 and	 in	 suspension	 is	 an	 absolute	 necessity	 to	 interpret	 results	 and	
formulate	 conclusions	 on	 the	 correlations	 between	 the	NP’s	 properties	 and	 the	 observed	
effects	29,	42.	From	these	issues	it	can	be	deducted	that	nanotoxicity	assessment	can	often	be	
more	complex	than	toxicity	testing	of	chemical	substances.	It	is	known	that	most	chemicals	
induce	 toxicological	 responses	 through	 interaction	 with	 specific	 biomolecules	 whereas	 a	
single	 type	 of	 NP	may	 cause	 toxicity	 via	 a	 combination	 of	 different	mechanisms	 like	 the	
induction	of	 reactive	oxygen	species	 (ROS),	genotoxicity,	morphological	modifications,	NP	
degradation	and	immunological	effects	31,	40,	43.	
Nel	 et	al.	 have	 put	 ROS	 induction	 forth	 as	 one	 of	 the	main	 common	 effects	 following	NP	
exposure	 and	 therefore	one	of	 the	main	mechanisms	 through	which	 inorganic	NP	 induce	
toxicity	as	it	has	been	observed	in	a	multitude	of	in	vivo	and	in	vitro	studies	44‐48.	For	instance,	
Wang	 et	al.	 observed	 a	 significant	 decrease	 in	 GSH/GSSH	 ratio	 in	 the	 olfactory	 bulb	 and	
hippocampus	in	mice	after	intranasal	exposure	to	IONP	49.	Soenen	et	al.	obtained	comparable	
results	 in	 an	 in	 vitro	 setting	 where	 C17.2	 neuronal	 progenitor	 cells	 showed	 a	 highly	





reactive	 surface	groups	or	 ions	 leached	 from	 the	NP	surface	 in	 the	acidic	environment	of	
endo‐	or	lysosomes	and	(iv)	by	activation	of	several	signalling	pathways	through	interaction	
with	cell	surface	receptors	28,	40.	This	paradigm	does	however	not	account	for	all	NP:	CeO2NP,	












the	 only	 route	 to	 genotoxicity	 as	 it	 is	 known	 that	 NP	 can	 also	 alter	 gene	 expression	 via	
interactions	with	signal	transduction	pathways	or	with	the	transcriptional	and	translational	
machinery	 through	perinuclear	 localisation	of	 the	NP	 56,	 57.	 	 Finally,	 very	 small	NP	with	 a	
diameter	below	5	nm	may	directly	interact	with	DNA	resulting	in	DNA	damage	58.	ROS	can	
furthermore	 cause	 actin	 stress	 fibre	 formation	 and	 therefore	 alter	 the	 cell’s	morphology,	


















initiate	an	 immune	 response	 20,	30.	The	protein	 corona	can	also	 stimulate	opsonisation	by	
macrophages	 in	vivo,	 thereby	 activating	 the	 complement	 system	and	 evoking	 an	 immune	
reaction	70.	Another	plausible	pathway	to	immunotoxicity	is	the	enhancement	of	an	allergic	
immune	 response,	 which	 by	 Nygaard	 et	 al.	 observed	 for	 single‐	 and	 multi‐walled	
carbonnotubes	(CNT)	in	mice	71,	72.		
In	the	current	nanotoxicity	paradigm,	ROS	induction	has	thus	been	set	forth	as	the	main	toxic	
effect	 caused	 by	 NP,	which	may	 (when	 sustained)	 lead	 to	 secondary	 effects.	 Other	 often	
observed	 toxicological	 responses	 are	 morphological	 alterations,	 genotoxicity,	
immunotoxicity	and	effects	 caused	by	 leached	 ions.	Each	of	 these	potential	effects	 should	













on	 characterisation	 of	NP	will	 not	 be	provided	here	 as	 this	 falls	 beyond	 the	 scope	 of	 the	







although	 the	 use	 of	 stem	 cells	 or	 primary	 cells	 is	 steadily	 increasing.	 The	 selection	 of	 a	
relevant	 cell	 type	and	source	generally	depends	on	 the	expected	 in	vivo	 target	organ	and	
application	of	the	NP	79.	In	the	vast	majority	of	the	studies	the	cells	are	exposed	to	the	NP	
dispersion	 during	 a	 single	 incubation	 period	 ranging	 from	 3	 up	 to	 48	 hours	 78,	 80,	 81.		
Afterwards,	the	induced	toxicity	is	evaluated	with	methods	that	were	initially	optimised	for	








every	newly	 synthetized	NP	 83,	 84.	Another	popular	 approach	 is	 staining	 the	 entire	 cell	 or	
specific	 cellular	 components	 with	 cellular	 dyes,	 fluorescently	 labeled	 antibodies	 (AB)	 or	
molecular	probes,	which	will	interact	with	a	specific	biomolecule	40,	78,	85.	The	samples	can	on	
the	one	hand	be	analyzed	using	a	plate	reader,	but	if	information	is	requested	on	the	variation	
between	 different	 cell	 types	 or	 status	 (e.g.	 apoptotic	 or	 not),	 flow	 cytometry	 is	 a	 more	
commonly	 used	 technique	 86‐89.	 On	 the	 other	 hand	 microscopic	 analysis	 can	 also	 be	
performed.	This	is	an	important	tool	for	evaluating	morphological	features	like	cell	spreading	
but	will	 also	 increasingly	 be	 applied	 to	 evaluate	 cellular	 processes	 in	 the	 context	 of	 high	
content	screening	90,	91.	The	use	of	such	stainings	in	combination	with	microscopy	however	
mostly	 generates	 qualitative	 or	 semi‐quantitative	 data.	 In	 order	 to	 generate	 quantitative	
data,	other	easily	quantifiable	assays	are	required	as	for	example	the	comet	assay,	PCR	or	
microarrays	to	evaluate	DNA	damage	78.		
Finally	 specialized	 techniques	 are	 used	 to	 evaluate	 specific	 parameters.	 For	 example,	 ion	
leaching	can	either	be	detected	in	cell‐free	conditions	using	specialized	buffers	(pH	7.4;	5.5	












and	 the	 pressure	 to	 develop	 a	more	 cost‐effective	 toxicity	 assessment	 protocol	 93,	 94.	 The	
European	Commission	has	bundled	 it’s	 guidelines	 in	 the	REACH	(Registration,	Evaluation	
and	 Administration	 of	 Chemicals)	 regulation.	 Even	 though	 this	 regulation	 was	 initially	
designed	for	chemical	substances	it	was	plainly	adopted	to	nanotoxicity	evaluation	95.	The	
approach	of	simply	adopting	REACH	regulations	to	NP	has	however	been	put	to	question	as	
classical	 toxicity	 assays	 show	major	 shortcomings	when	 they	 are	 applied	 to	 nanotoxicity	
assessment,	as	will	be	discussed	in	section	2.4.	For	assay	protocols	REACH	in	turn	refers	to	








A	 commonly	 used	 technique	 for	 in	 vivo	 studies	 is	 the	 histopathological	 examination	 of	
selected	 organs	 and	 tissues	 from	 a	 sacrificed	 animal,	 often	 in	 combination	 with	 an	
appropriate	staining	94.	This	technique	is	used	for	all	required	aspects	except	for	the	skin	and	








then	be	 clarified	 by	 the	molecular	mechanism	 found	 in	 in	vitro	 experiments.	REACH	also	
requires	blood	and	urine	samples	to	be	taken	at	regular	time	points,	the	weight	of	the	animal	
to	 be	 documented	 as	 well	 as	 its	 behaviour	 and	 food	 and	 water	 consumption	 94.	 When	

























Currently,	 methods	 applied	 for	 evaluating	 NP	 toxicity,	 such	 as	 biochemical	 cell	 viability	




effects	 it	 evokes	 29,	 101‐103.	 This	 led	 to	 an	 increasing	 awareness	 that	 these	 methods,	 and	




















parameter,	 for	 example	 surface	 charge,	 without	 affecting	 any	 other	 (hydrodynamic	 size,	
colloidal	stability,	nature	of	the	coating…)	is	not	an	easy	task	105.	Therefore	a	multitude	of	







most	 relevant	 105.	 Which	 was	 pointed	 out	 in	 a	 review	 by	 Johnston	 et	 al.,	 as	 they	 often	
encountered	 a	 stronger	 toxic	 response	 for	 the	 smaller	 NP	 in	 comparison	 to	 their	 larger	
counterparts	at	similar	mass/volume	doses	38.	It	was	suggested	by	Wittmaack	that	particle	
number/volume	 might	 be	 the	 best	 dose	 metric	 108.	 Other	 groups	 however	 suggested	 to	
express	the	concentration	in	terms	of	surface	area/volume	as	it	is	known	that	toxicological	
responses	depend	on	 the	NP’s	 surface	properties	 and	 that	 the	 surface	 area	 exponentially	
increases	with	a	decrease	in	NP	size	45,	106,	109.	The	applicability	of	this	unit	was	demonstrated	




distinct	 physicochemical	 properties,	 when	 the	 concentration	 was	 expressed	 in	 surface	
area/volume	and	the	steepest	slope	method	was	applied	110.	When	the	same	group	applied	
this	method	to	results	from	Sayes	et	al.,	who	could	not	obtain	an	in	vitro‐in	vivo	correlation	
back	 in	2007,	a	 clear	correlation	was	now	established110,	111.	Han	et	al.	 also	 found	a	clear	
correlation	 when	 comparing	 the	 oxidative	 stress	 in	 vitro	 and	 the	 in	 vivo	 inflammatory	
response	after	TiO2NP	exposure,	confirming	the	applicability	of	the	steepest	slope	method	
using	surface	area/volume	as		dose	metric	112.		
Subsequently	 attention	 should	 go	 to	 standardisation	 of	 nanotoxicity	methods	 in	 terms	 of	
incubation	conditions	like	NP	concentration	and	incubation	time	as	overexposure	conditions	
should	be	avoided	113.	The	importance	of	avoiding	overexposure	conditions	becomes	clear	
when	 evaluating	 genotoxicity	 for	 example,	 as	 acute	 toxicity	 at	 overexposure	 levels	 can	
mistakenly	be	interpreted	for	genotoxicity	since	apoptosis	itself	induces	DNA	fragmentation	
114,	115.	This	implies	the	need	to	screen	for	genotoxicity	at	sublethal	levels.	The	determination	
of	 relevant	 dose	 ranges	 is	 however	 severely	 hampered	 by	 the	 lack	 of	 exposure	 data	 and	
required	doses	of	NP	for	specific	applications.	Therefore	in	vitro	(and	in	vivo)	toxicity	testing	
currently	focuses	on	determination	of	the	No	Observed	Adverse	Effect	Level	(NOAEL)	values	









the	 development	 of	 methods	 to	 create	 a	 stable	 and	 uniform	 dispersion	 via	 surface	
modification,	addition	of	surfactants	etc.	118‐120.	But	opposing	opinions	exist	on	whether	NP	
agglomerates	must	be	redispersed	before	addition	 to	 the	cells	or	not	since	results	 from	a	
study	by	Oberdörster	et	al.	 in	which	surfactant	stabilised	dispersions	were	used,	has	been	
put	to	question	as	the	observed	toxicity	might	have	been	caused	by	surfactant	residuals	121.	






mechanisms	are	 interactions	with	 enzymes	or	 substrates	because	of	 the	high	absorbance	
capacity	and/or	catalytic	activity	of	the	NP	82,	104.	Han	et	al.	saw	this	for	AgNP	and	TiO2NP,	
which	respectively	 inactivated	and	adsorbed	to	LDH	 leading	 to	an	underestimation	of	 the	
acute	toxicity	124.	Kroll	et	al.	 looked	into	the	interference	of	24	well‐characterised	NP	with	
four	 frequently	used	 in	vitro	assays	and	observed	concentration,	NP	and	assay‐dependent	




(no	 treatment)	and	positive	control	 (maximum	effect),	which	should	be	 included	 in	every	
assay	when	possible,	the	positive	control	can	also	be	tested	in	combination	with	the	NP.	The	












The	major	 issue	for	 in	vivo	nanotoxicity	testing	 is	the	set	up	of	a	relevant	dose	range	that	














currently	 no	 standard	 protocols	 are	 available	 for	 this	 type	 of	 study,	 optimization	 is	 still	
18	
	




focused	 on	 developing	methods	 to	 create	 stable	 and	 uniform	 dispersions	 in	 a	 controlled	



























Thus,	 it	 can	be	 stated	 that	both	 in	vitro	and	 in	vivo	methods	 cannot	be	plainly	 applied	 to	
nanotoxicity	studies	and	that	the	entire	nanotoxicity	testing	paradigm	should	be	subject	to	


















Teeguarden	 et	 al.	 proposed	 the	 concept	 of	 particokinetics,	 representing	 the	 solution	
dynamics	 of	 the	 NP	 116.	 They	 marked	 diffusion,	 sedimentation	 and	 aggregation	 as	
predominant	 processes	 determining	 the	 NP’s	 faith	 in	 dispersion.	 Subsequently	 they	
suggested	a	distinction	between	the	administered,	delivered	and	cellular	dose	respectively	
being	 the	 dose	 added	 to	 the	 cell	 culture,	 the	 dose	 reaching	 the	 cell	 surface	 and	 the	 dose	
actually	reaching	the	interior	of	the	cell	(Figure	1).	The	latter	dose	is	the	most	interesting	for	
nanotoxicity	and	cell	 labelling	studies	but	 is	also	 the	hardest	 to	determine.	Until	methods	

















This	 method	 should	 include	 the	 evaluation	 of	 different	 endpoints	 via	 multiple	 assays	
preferably	in	multiple	cell	types	from	different	organisms	to	increase	the	predictive	power	









simultaneous	 testing	of	multiple	doses	 in	different	 cell	 types	by	using	various	assays	 in	a	
reasonable	amount	of	time	128,	133.	This	screening	approach	appears	to	be	very	promising	as	
O’Brien	 et	al.	 found	 a	 sensitivity	 and	 specificity	 of	 respectively	 93%	 and	 98%	 for	 a	 five‐
parameter	 HCS	 method	 in	 comparison	 to	 a	 single	 parameter	 approach	 that	 showed	 a	








bottleneck	 of	 nanotoxicity	 testing	 to	 shift	 from	 the	 assay	 execution	 to	 data	 processing.	







on	 their	 physicochemical	 properties	 enabling	 an	 even	 faster	 evolution	of	nanotechnology	















Novelties	 to	 in	 vivo	 methods	 are	 not	 as	 numerous	 as	 for	 their	 in	 vitro	 counterparts,	 but	
recently	some	research	has	been	performed	on	the	use	of	zebrafish	embryos	for	an	in	vivo	
screening	approach.	Similar	as	for	most	 in	vitro	methods	used	in	nanotoxicity	assessment,	
Hill	 et	 al.	 initially	 developed	 this	 method	 for	 the	 evaluation	 of	 the	 toxicity	 of	 chemical	
substances	 139.	 Usenko	 et	al.	 subsequently	 demonstrated	 the	 suitability	 of	 this	model	 for	
nanotoxicity	 evaluation	 and	 follow‐up	 studies	 examining	 AuNP,	 AgNP	 and	 QD	 toxicity	








most	 important	 innovations	 for	 in	 vitro	 methods	 in	 the	 recent	 years	 are	 the	 concept	 of	
particokinetics	 and	 the	 development	 of	mutiparametric	methods.	 The	 latter	 initiated	 the	












unintentionally	 during	 the	 long	 cultivation	 time	 and	 extensive	 in	 vitro	 manipulation	 or	
intentionally	during	their	immortalization	145,	146.	Alterations	may	include	changes	in	cellular	
homeostasis,	growth	potential,	biological	responses,	signal	transduction	etc.	Hence,	doubts	




cells	or	stem	cells	has	been	put	 forward	as	an	alternative	as	 it	 is	assumed	that	these	cells	
stand	closer	to	the	in	vivo	cellular	situation	as	they	undergo	minimal	manipulation	in	vitro	in	
comparison	 to	 cell	 lines	 146,	 147.	 But,	 since	 these	 cells	 are	 not	 always	 easily	 obtained	 and	
require	specific	handling,	this	assumption	first	needs	to	be	proven	by	comparative	studies	in	





































final	 toxic	 response	 and	 appear	 to	 differ	 between	 cell	 types,	 several	 studies	 have	 been	
conducted	 comparing	 these	 parameters	 in	 different	 cell	 types.	 For	 example,	 Sur	 et	 al.	
compared	the	uptake	of	AgNP	modified	with	glucose,	lactose	or	oligonucleotides	in	L929	and	














151‐153.	 All	 other	 cell	 types	 tested	 did	 not	 show	 a	 significant	 uptake.	 The	 authors	 have	








phenotypically	 closely	 related	human	prostate	 cancer	 cell	 lines,	 as	 can	be	deducted	 from	
Figure	3.	It	was	observed	that	the	QD	were	trapped	in	lysosomes	scattered	throughout	the	
cytoplasm	in	PC3	cells,	 localized	at	a	single	 juxtanuclear	 location	in	PC3‐PSMA	cells	and	a	
combination	of	both	was	found	in	PC3‐flu	cells	156.	They	coupled	these	observations	to	the	
loss	of	polarity	in	malignant	cells	influencing	the	sorting	and	trafficking	potency	of	the	cells,	
the	 slight	 differences	 in	 receptor	 expression	profiles	 and	 a	 disruption	 of	 the	microtubule	
network	in	PC3	cells	impeding	further	trafficking	to	the	juxtanuclear	region	156.	
It	can	be	concluded	from	these	data	that	cellular	uptake	and	distribution	of	NP	depends	on	





































hepatoma	cell	 line	 159.	When	Wang	et	al.	 compared	the	 toxicity	of	FITC‐encapsulated	SiO2	
core/ZnO	 shell	 NP	 in	 the	 Jurkat	 cell	 line	 and	 primary	 T‐lymphocytes,	 which	 were	 less	

























Furthermore,	Mukherjee	et	al.	 have	put	 the	cells	natural	 antioxidant	 levels	 forward	as	an	
important	factor.	They	coupled	the	higher	susceptibility	of	HeLa	cells	in	comparison	to	HaCaT	






























are	published	on	 the	 subject.	 The	 level	 of	 cellular	differentiation	also	 appears	 to	have	an	
influence	 since	 more	 differentiated	 primary	 cells	 were	 found	 to	 be	 more	 susceptible	 to	
nanotoxicity	in	several	studies.	These	differences	in	sensitivity	may	largely	be	explained	by	
variations	 in	 cell	 function	 influencing	 NP	 uptake,	 metabolic	 activity,	 natural	 antioxidant	
activity	 and	 proliferative	 capacity.	 These	 data	 underscore	 the	 importance	 of	 selecting	 a	
relevant	cell	system	for	hazard	assessment,	which	is	a	balancing	act	since	both	primary	cells	













In	 a	 similar	 setup	 as	 for	 chemicals,	 NP	 hazard	 is	 mostly	 evaluated	 in	 classical	 2D	
monocultures.	 As	 chemical	 substances	 typically	 dissolve	 in	 the	 cell	 medium,	 the	 dose	 to	
which	the	cells	are	exposed	to	is	accurately	represented	by	the	concentration	of	the	chemical	
in	 the	solution.	 In	 first	 instance	 it	was	assumed	that	 this	also	applied	to	NP,	as	 they	were	
thought	to	be	evenly	dispersed	by	Brownian	motion	35.	But	this	appeared	not	to	be	true	since	
NP	 in	 dispersion	 are	 not	 only	 subject	 to	 diffusion	 but	 also	 to	 sedimentation	 and	
agglomeration	116.	Therefore	the	concept	of	dose	is	more	complex	and	dynamic	for	NP	as	it	is	





since	 both	 terms	 are	 often	mixed	 up:	 aggregates	 are	 formed	 by	 covalent	 bonds	 and	 are	
therefore	not	as	easy	to	break	up	as	agglomerates,	which	are	held	together	by	van	der	Waals	
forces,	hydrophobic	interactions	and/or	hydrogen‐bonds	170.	The	formation	of	agglomerates	


























will	 be	 added	 to	 the	 cells.	Dynamic	 light	 scattering	 (DLS)	 is	 a	 successful	 technique	but	 is	
limited	to	samples	in	simple	or	diluted	media	as	other	light	scattering	components,	such	as	
serum	 proteins,	 can	 interfere	 with	 the	 measurements	 177.	 It	 would	 however	 be	 more	
convenient	 if	 NP	 size	 and	 agglomeration	 could	 be	 studied	 in	 undiluted	 biological	 fluids.	














400	 nm	 diameter	 agglomerates	 in	 a	 human	 long‐lived	 fibroblast	 cell	 line	 (MRC‐9).	 They	




observations	 from	 Drescher	 et	 al.	 who	 found	 higher	 uptake	 for	 the	 single	 NP	 and	 small	
agglomerates	 in	 comparison	 to	 their	 larger	 counterparts	 in	 3T3	 fibroblasts	 175.	 These	
observations	 fit	 the	 assumption	 that	 larger	 aggregates	do	not	 enter	 the	 cell	 via	 the	 same	
mechanism	as	single	NP	or	small	agglomerates	since	most	common	endocytosis	routes	like	
clathrin‐	 or	 caveolin‐mediated	 endocytosis	 are	 limited	 to	 the	 uptake	 of	 materials	 with	






Finally	 Lankoff	 et	 al.	 observed	 differential	 uptake	 of	 single	 AgNP,	 TiO2NP	 and	 their	
agglomerates	in	HepG2,	A549	and	THP‐1	cells,	adding	NP	type‐dependency	to	the	picture	147.		
From	 the	 available	 (conflicting)	 data	 it	 cannot	 be	 concluded	whether	 single	 NP	 or	 small	
agglomerates	are	taken	up	to	a	higher	or	lesser	extent	by	the	cells.	Reviewing	these	data,	we	
do	hypothesize	that	following	factors	are	equally	important;	(i)	the	extent	of	agglomeration,	
(ii)	 the	 size	 of	 the	 agglomerates	 and	 (iii)	 the	 cellular	 uptake	 mechanism.	 The	 extent	 of	
agglomeration	 and	 the	 size	 of	 the	 agglomerates	 will	 not	 only	 determine	 the	 rate	 of	
sedimentation,	and	hereby	the	rate	of	NP	transport	 towards	the	cells,	but	also	 the	way	 in	
which	the	cells	will	handle	these	materials.	Non‐specialized	cells	will	typically	prefer	smaller	












CNT	178.	 In	contrast,	 some	studies	show	that	cytotoxicity	 is	 reduced	 for	agglomerated	NP,	
which	is	possibly	due	to	the	fact	that	smaller	entities	are	in	general	taken	up	more	avidly	by	


















Following	 on	 from	 the	 sections	 above,	 it	 is	 clear	 that	 sedimentation	 is	 one	 of	 the	major	
shortcomings	to	classical	2D	cultures.	Since	sedimentation	is	not	observed	in	vivo	and	was	
demonstrated	to	affect	nanotoxicity	in	vitro,	several	groups	have	tried	to	develop	novel	model	









not	 result	 in	 increased	 cellular	 exposure	 levels	 for	 cells	 that	 are	 cultured	 in	 the	 inverted	
configuration.	 The	 authors	 observed	 a	 much	 more	 avid	 uptake	 of	 NP	 in	 classical	 cell	




























membrane	blebbing	under	 flow	 conditions,	where	 cells	 under	 static	 conditions	 showed	a	




flow	 and	 static	 conditions.	 Lin	 et	al.	 for	 instance	 found	 a	 higher	 uptake	 of	 functionalised	
polystyrene	NP	in	activated	human	aortic	endothelial	cells	(HAEC)	in	the	classical	2D	setup	










4.5	 dyn/cm2)	 and	 observed	 the	 highest	 adherence	 and	 uptake	 under	 the	 lowest	 SS	 187.	






























condition,	while	 non	 targeted	NP	 show	higher	 uptake	under	 static	 conditions.	Results	 on	
nanotoxicity	 are	 on	 the	 contrary	 conflicting	 so	no	 firm	 conclusions	 can	be	drawn	on	 this	
subject	yet.	But,	as	toxicity	levels	measured	in	these	novel	model	systems	significantly	differ	
from	those	obtained	from	classical	static	2D	monocultures	and	the	former	are	believed	to	be	




















of	 xenobiotics,	 inflammation	 and	 immune	 responses.	 It	 is	 therefore	 a	major	 challenge	 to	
accurately	model	these	processes	in	vitro.	Consequently,	several	processes	like	inflammation	
or	 immune	 responses	 cannot	 be	 accurately	modelled	 in	monocultures	 190,	 191.	 In	 order	 to	






















uptake	 of	 all	NP	 in	MDM	and	 the	 least	 uptake	 in	A549	 cells	 (Figure	 6).	 Compared	 to	 the	





nerve	 graft	 co‐culture,	 the	 highest	 uptake	 was	 observed	 in	 the	 microglia,	 which	 are	 the	
resident	 macrophages	 of	 the	 CNS	 195.	 Since	 both	 studies	 show	 a	 preferential	 uptake	 in	
macrophages	 due	 to	 their	 phagocytotic	 capacity,	 this	 effect	 should	 be	 taken	 into	 account	















up	high	 levels	of	 these	NP,	 this	may	result	 in	strong	reactions	 that	naturally	occur	within	
these	cells	when	dealing	with	pathogens,	including	the	generation	of	a	strong	oxidative	burst	
or	 secretion	of	pro‐inflammatory	 cytokines,	which	may	 then	affect	 any	 surrounding	 cells.	
This	 secondary	 damage,	 induced	 by	 the	 macrophages,	 would	 never	 be	 picked	 up	 in	























in	 a	 RAW264.7/MLE12	 (murine	 alveolar	 long‐lived	 cell	 line)	 co‐culture	 and	 both	
monocultures	they	found	the	co‐culture	to	be	more	susceptible	to	apoptotic	damage,	which	
was	explained	by	 the	 increased	TNFα	 release	by	 the	RAW264.7	 cells	 and	 therefore	 to	 the	
intercellular	communication	198.		
Another	popular	combination	consists	of	alveolar	epithelial	and	microvascular	endothelial	
cells	 to	mimic	 the	 air‐blood‐barrier.	 Culture	 inserts	 separate	 the	 two	 cell	 types	 and	 only	
epithelial	cells	(representing	the	apical	membrane)	are	exposed	to	NP.	Using	this	model,	the	
potential	 to	 activate	 endothelial	 cells,	 which	 can	 subsequently	 induce	 systemic	 effects,	
through	intercellular	communication	can	be	evaluated.	Kasper	et	al.	evaluated	the	toxicity	
induced	 by	 35	 nm	 diameter	 SiO2NP	 in	 the	 H441/ISO‐HAS‐1	 co‐culture	 and	 H441	
monoculture.	They	found	the	co‐culture	to	be	more	resilient	to	nanotoxicity	in	terms	of	acute	











adhesion	molecules,	 a	3	 to	4‐fold	 increase	 in	monocyte	adhesion	and	a	2‐fold	 increase	 in	




agglomeration	of	 the	NP.	This	supports	 the	hypothesis	 that	endothelial	cells	are	activated	
through	intercellular	communication	after	exposure	of	epithelial	cells	to	NP.		
Since	it	was	shown	that	macrophages	can	have	an	effect	on	the	toxicity	observed	in	epithelial	
cells,	 several	 groups	 investigated	 whether	 the	 activation	 status	 of	 macrophages	 has	 an	












cells	 combined	 with	 either	 C57BL/6J	 mice	 neutrophils	 or	 C57BL/6J	 mice	 macrophages	
without	 culture	 inserts.	 The	 macrophages	 protected	 A549	 cells	 against	 oxidative	 DNA	
damage	whereas	the	neutrophils	aggravated	the	effect	203.		
Some	 groups	 added	 one	 or	 more	 additional	 cell	 types	 to	 create	 an	 even	 more	 complex	
environment.	 For	 example	 Alfaro‐Moreno	 et	 al.	 evaluated	 the	 effects	 of	 PM10	 in	 several	
combinations	 of	 cell	 lines:	 A549/HMC‐1,	 THP‐1/HMC‐1,	 A549/THP‐1/HMC‐1	 and	
A549/THP‐1/HMC‐1/EAhy296.	All	cultures	had	a	distinct	cytokine	excretion	profile	with	the	
co‐culture	of	mast	cells	(HMC‐1)	and	macrophages	(THP‐1)	showing	a	synergistic	increase	in	





and	 TiO2NP	 in	 a	 co‐culture	 consisting	 of	 A549,	 MDC	 and	 MDDC	 and	 the	 corresponding	
monocultures.	 They	 found	 that	 the	 interaction	 between	 the	 cells	 modulated	 the	 total	





















is	 the	 loss	 of	 the	 specific	 3D	 tissue	 architecture	 and	 associated	with	 this,	 the	 loss	 of	 cell	

















and	 differentiation	 209.	 	 It	 was,	 for	 example,	 shown	 by	 Kuo	 et	 al.	 that	 the	 epithelial‐








are	 however	 likely	 to	 be	 not	 very	 useful	 for	 NP	 studies	 as	 thick	 scaffolds	 will	 limit	 the	
diffusion	of	NP	towards	the	cells,	which	will	drastically	alter	the	outcome	of	any	uptake	or	
toxicity	studies.	 Initially	many	research	groups	applied	these	3D	models	 in	 in	vitro	cancer	










uptake	 in	 a	 2D	 and	 3D	 setting.	 For	 instance	 Mitra	 et	 al.	 found	 a	 slow	 diffusion	 and	
heterogeneous	distribution	of	anti‐cancer	drug	loaded	NP	in	Y79	(retinoblastoma)	spheres	
in	comparison	to	an	even	distribution	in	classical	monocultures	of	the	same	cells.	The	naïve	
drugs	 on	 the	 other	 hand	 were	 distributed	 homogeneously	 throughout	 the	 spheres	 212.	






















simultaneously	 in	2D	and	3D	cultures.	 In	 the	context	of	 the	 initial	application	of	spheroid	
models,	Godugu	et	al.	 evaluated	 the	anti‐proliferative	 capacity	of	dox‐loaded	NP	on	 three	
different	 human	 non	 small	 cell	 lung	 carcinoma	 spheres	 (H460,	 A549	 and	 H1650)	 in	
comparison	to	the	same	cells	cultured	in	a	2D	monolayer.	They	found	significantly	altered	
toxicological	profiles	as	 IC50	values	were	elevated	5	 to	20	 times	 in	 the	3D	setup,	which	 is	










more	 severe	 damage	 to	 the	 cells	 in	 periphery	 of	 the	 sphere	while	 the	 interior	 remained	
unimpaired,	while	when	the	same	incubation	conditions	were	applied	to	2D	cultures	more	
overall	cell	death	was	observed	(Figure	8).	They	attributed	these	effects	 to	 the	protective	
effect	 of	 the	 barrier	 consisting	 of	 the	 ECM	 layer	 secreted	 by	 the	 cells	 and	 the	 dead	 cells	
remaining	on	 the	exterior	of	 the	sphere,	due	 to	 the	 tight	packing	of	 the	cells,	 temporarily	
enhancing	the	efficiency	of	the	barrier	215.	Luo	et	al.	obtained	similar	results	when	evaluating	
CdSe/ZnS	QD,	IONP	and	SiNP	toxicity	in	HeLa	microspheres	as	they	found	nanotoxicity	to	be	






















on	 the	cellular	phenotype	and	 function	and	therefore	causes	cells	 to	react	 in	a	drastically	
different	manner	 to	NP	exposure.	Results	 from	experiments	 in	a	3D	 setup	 therefore	vary	























of	 NP	 uptake	 and	 toxicity	 in	 advance	 of	 any	 in	 vivo	 applications.	 Where	 the	 field	 of	
nanotoxicology	is	advancing	fast,	it	is	still	lagging	behind	the	rapid	developments	in	the	field	
of	nanotechnology.	The	great	number	of	different	 types	of	materials,	each	with	 their	own	
specific	 features	 and	 the	 heavy	 impact	 of	 even	 the	 most	 miniature	 changes	 in	 a	 single	
physicochemical	parameter	of	a	NP	on	its	 interaction	with	biological	entities	make	it	very	
hard	to	thoroughly	evaluate	the	interactions	of	nanomaterials	with	cells	or	tissues.	Where	in	
vitro	 studies	 are	 now	 often	 being	 performed	 by	 many	 research	 groups	 and	 are	 being	
optimized	more	and	more	in	order	to	overcome	some	of	the	initial	hurdles,	in	vivo	studies	
remain	scarce.	The	most	used	in	vitro	model,	namely	the	classical	2D	monoculture,	is	however	
a	 very	 reductionist	 approach	were	most	of	 the	 complexity	of	 the	 in	 vivo	 situation	 is	 lost.	
Therefore,	 results	 from	 in	 vitro	 studies	 often	 did	 not	 relate	 very	 well	 with	 the	 findings	
obtained	 in	 in	vivo	 studies.	 Several	 groups	have	 subsequently	made	 substantial	 efforts	 in	
trying	 to	 optimize	 the	 current	 in	 vitro	 models	 to	 better	mimic	 the	 in	 vivo	 conditions.	 As	
described	in	the	various	sections	above,	the	use	of	 inverted	cell	cultures,	 flow	models,	co‐
cultures	 or	 3D	 cell	 cultures	 all	 have	 their	 advantages	 compared	 to	 the	 classical	 2D	
monolayers	used	for	NP	uptake	and	toxicity	studies.	
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